Risk management involves quantifying hazard (toxicity) and exposure, and taking the necessary steps to reduce both to acceptable levels, ideally at an early stage of the nanomaterial development process (Safe-by-Design). Various industrial sectors, and in particular structural or functional materials, coatings and cosmetics, as well as pharma and health technology are currently searching for ways to mitigate possible risks from nanomaterials and nano-containing products. The challenge now is to distil existing methods into simple, robust, cost-effective methods for monitoring and modelling of physical-chemical properties and biological effect assessment of nanomaterials in relevant use conditions including in product-relevant matrices.Scope:
In line with the strategy for EU international cooperation in research and innovation (COM(2012)497), international cooperation is particularly encouraged.
Proposals submitted under this topic should include actions designed to facilitate cooperation with other projects; to enhance user involvement; and to ensure the accessibility and reusability of data produced in the course of the project.
Activities should start at TRL 4 and achieve TRL 6 at the end of the project.
The Commission considers that proposals requesting a contribution from the EU between EUR 5 and 6 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.Expected Impact: